首页 | 本学科首页   官方微博 | 高级检索  
检索        

美常安联合六味安消治疗慢性功能性便秘的疗效观察
引用本文:黄金龙,容海鹰,朱雅丽等.美常安联合六味安消治疗慢性功能性便秘的疗效观察[J].中国医药指南,2014(13):14-15.
作者姓名:黄金龙  容海鹰  朱雅丽等
作者单位:广东药学院附属第二医院广州新海医院消化内科,广东广州510300
摘    要:目的评价美常安联合六味安消治疗慢性功能性便秘的疗效。方法慢性功能性便秘患者89例,采用平行、双盲、随机的方法分为三组,A组(n=31)口服美常安+六味安消,B组(n=30)口服美常安,C组(n=28)口服六味安消,治疗疗程为4周。结果治疗4周后,三组总缓解率分别为96.77%,53.33%,57.14%,A组显著高于B和C两组(P<0.05)。结论美常安联合六味安消治疗慢性功能性便秘优于单用一种药物,且效果明显,安全有效,值得临床推广应用。

关 键 词:功能性便秘  美常安  六味安消  联合治疗

The Therapeutic Effects of Medilac-S with Liuwei-Anxiao on Chronic Functional Constipation
HUANG Jin-long,RONG Hai-ying,ZHU Ya-li,ZHANG Ming.The Therapeutic Effects of Medilac-S with Liuwei-Anxiao on Chronic Functional Constipation[J].Guide of China Medicine,2014(13):14-15.
Authors:HUANG Jin-long  RONG Hai-ying  ZHU Ya-li  ZHANG Ming
Institution:(Department of Gastroenterology, The Second Affiliate Hospital of Guangdong Pharmaceutical University (Xinhai Hospital of Guangzhou), GuangDong 510300, China)
Abstract:Objective To evaluate abstract the therapeutic effects of Medilac-S combined with Liuwei-Anxiao on chronic functional constipation. Methods 89 patients with chronic functional constipation were randomly divided into 3 groups: Medilac-S plus Liuwei-Anxiao group(A,n=31),Medilac-S group(B,n=30), Liuwei-Anxiao group(C,n=28),the treatment lasted for 4 weeks.Results After 4 weeks of treatment, the total remission rates were 96.77%, 53.33%, 57.14% respectively in group A, B and C, A group was significantly higher than that of B and C groups (P&lt;0.05).Conclusion Combined use of Medilac-S with Liuwei-Anxiao on chronic functional constipation is better than one drug alone, and the results are obvious, safe,and effective, worthy of clinical application.
Keywords:Functional constipation  Medilac-S  Liuwei-Anxiao  Therapeutic alliance
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号